A physiologically-based kinetic (PBK) model for work-related diisocyanate exposure: relevance for the design and reporting of biomonitoring studies

[1]  M. J. Silva,et al.  HBM4EU Diisocyanates Study—Research Protocol for a Collaborative European Human Biological Monitoring Study on Occupational Exposure , 2022, International journal of environmental research and public health.

[2]  Stephen W. Edwards,et al.  Predicting nonlinear relationships between external and internal concentrations with physiologically based pharmacokinetic modeling. , 2022, Toxicology and applied pharmacology.

[3]  L. Godderis,et al.  Biomonitoring for Occupational Exposure to Diisocyanates: A Systematic Review , 2020, Annals of work exposures and health.

[4]  S. Woskie,et al.  Assessment and control of exposures to polymeric methylene diphenyl diisocyanate (pMDI) in spray polyurethane foam applicators. , 2019, International journal of hygiene and environmental health.

[5]  D. Bernstein,et al.  Comparison of biological effects with albumin adducts of 4,4′-methylenediphenyl diisocyanate in workers , 2017, Archives of Toxicology.

[6]  R. Sauni,et al.  Role of dermal exposure in systemic intake of methylenediphenyl diisocyanate (MDI) among construction and boat building workers. , 2015, Toxicology letters.

[7]  P. Harber,et al.  Isocyanates and Human Health: Multistakeholder Information Needs and Research Priorities , 2015, Journal of occupational and environmental medicine.

[8]  J. Heaf,et al.  Indexing Glomerular Filtration Rate to Body Surface Area: Clinical Consequences , 2014, Journal of clinical laboratory analysis.

[9]  K. Broberg,et al.  Biomarkers of exposure in Monday morning urine samples as a long-term measure of exposure to aromatic diisocyanates , 2014, International Archives of Occupational and Environmental Health.

[10]  George Loizou,et al.  Reconstruction of Exposure to m-Xylene from Human Biomonitoring Data Using PBPK Modelling, Bayesian Inference, and Markov Chain Monte Carlo Simulation , 2012, Journal of toxicology.

[11]  T. Geens,et al.  Air exposure assessment of TDI and biological monitoring of TDA in urine in workers in polyurethane foam industry , 2011, Occupational and Environmental Medicine.

[12]  C. Lemière,et al.  Elimination kinetics of diisocyanates after specific inhalative challenges in humans : mass spectrometry analysis , as a basis for biomonitoring strategies , 2011 .

[13]  E. Fabian,et al.  Dermal uptake and excretion of 14C-toluene diisocyante (TDI) and 14C-methylene diphenyl diisocyanate (MDI) in male rats. Clinical signs and histopathology following dermal exposure of male rats to TDI. , 2010, Toxicology letters.

[14]  Anoop Kumar,et al.  Determination of a new biomarker in subjects exposed to 4,4′-methylenediphenyl diisocyanate , 2010, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[15]  C. Redlich.  Skin exposure and asthma: is there a connection? , 2010, Proceedings of the American Thoracic Society.

[16]  M. Chan-yeung,et al.  Agents causing occupational asthma. , 2009, The Journal of allergy and clinical immunology.

[17]  S. Austin.  Biological monitoring of TDI-derived amines in polyurethane foam production. , 2007, Occupational medicine.

[18]  Dhimiter Bello,et al.  Skin Exposure to Isocyanates: Reasons for Concern , 2006, Environmental health perspectives.

[19]  B. Jönsson,et al.  Biological monitoring of exposure to 1,5–naphthalene diisocyanate and 4,4’-methylenediphenyl diisocyanate , 2006, International archives of occupational and environmental health.

[20]  P. Hext,et al.  Absorption, distribution, metabolism and excretion of an inhalation dose of [14C] 4,4'-methylenediphenyl diisocyanate in the male rat , 2005, Xenobiotica; the fate of foreign compounds in biological systems.

[21]  B. Jönsson,et al.  A survey of airborne isocyanate exposure in 13 Swedish polyurethane industries. , 2004, The Annals of occupational hygiene.

[22]  B. Jönsson,et al.  Development, validation and characterization of an analytical method for the quantification of hydrolysable urinary metabolites and plasma protein adducts of 2,4- and 2,6-toluene diisocyanate, 1,5-naphthalene diisocyanate and 4,4'-methylenediphenyl diisocyanate , 2003, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[23]  J. Valentin.  Basic anatomical and physiological data for use in radiological protection: reference values , 2002, Annals of the ICRP.

[24]  J. Hutter,et al.  Pharmacokinetic modeling of 4,4'-methylenedianiline released from reused polyurethane dialyzer potting materials. , 2000, Journal of biomedical materials research.

[25]  F. Llados,et al.  Toxicological profile for methylenedianiline , 1998 .

[26]  H. F. Bushar,et al.  A physiologically based pharmacokinetic model for 2,4-toluenediamine leached from polyurethane foam-covered breast implants. , 1998, Environmental health perspectives.

[27]  L. Hagmar,et al.  Toxicokinetics of 2,4- and 2,6-toluenediamine in hydrolysed urine and plasma after occupational exposure to 2,4- and 2,6- toluene diisocyanate. , 1996, Occupational and environmental medicine.

[28]  O. Sepai,et al.  Albumin adducts, hemoglobin adducts and urinary metabolites in workers exposed to 4,4'-methylenediphenyl diisocyanate. , 1995, Carcinogenesis.

[29]  O. Sepai,et al.  Biomonitoring of workers exposed to 4,4'-methylenedianiline or 4,4'-methylenediphenyl diisocyanate. , 1995, Carcinogenesis.

[30]  T. Brorson,et al.  Biological monitoring of isocyanates and related amines , 1991, International archives of occupational and environmental health.